Intraoral Giant Cell Fibroma in a Young Patient with Tuberous Sclerosis Complex: A Case Report of a Rare Occurrence Authors: Olando Kevin D'souza, Rashmi Naik, Siya Dukle, Karla Carvalho Published: 2025 ABSTRACT AbstractAim and backgroundTuberous sclerosis complex (TSC) is a rare genetic disorder characterized by multisystem hamartomas. Oral manifestations in the form of gingival enlargement, enamel pitting, and fibromas are a common finding. The most common form of fibromas reported in these patients has been angiofibromas, predominantly located on the anterior gingival mucosa. Here, we report a case of an intraoral giant cell fibroma, which, to the best of our knowledge, has not been reported to date.Case descriptionA 12-year-old girl, prediagnosed with TSC, presented with a soft tissue swelling originating from the interdental papilla between the left mandibular permanent lateral incisor and canine. An excisional biopsy was performed. Histopathological analysis was carried out.ConclusionA final diagnosis of a giant cell fibroma was made. No evidence of lesion recurrence was reported at the end of a 1-year follow-up.Clinical significanceDifferential diagnosis of a giant cell fibroma can be considered in patients with TSC presenting with intraoral fibrous lesions. Timely interventions will help improve the oral health-related quality of life of these patients.How to cite this articleD'souza OK, Naik R, Dukle S, et al. Intraoral Giant Cell Fibroma in a Young Patient with Tuberous Sclerosis Complex: A Case Report of a Rare Occurrence. Int J Clin Pediatr Dent 2025;18(12):1504–1506. Introduction Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder associated with frequent spontaneous mutations.1 Its prevalence has been estimated at one in 14,000 to 25,000 live births, with most cases being diagnosed within the first 15 months of age.2 Oral findings frequently include enamel pitting and the presence of intraoral angiofibromas.3 There is no literature reporting the occurrence of an intraoral giant cell fibroma in patients with TSC. Hence, this case report is unique in its kind. Case Description A 12-year-old girl reported to the Department of Pedodontics with a swelling on the mandibular anterior gingiva for 2 years. The patient was diagnosed with TSC in the first year of life and presented with facial angiofibromas on the nose and cheeks (Fig. 1A), along with shagreen patches on the back (Fig. 1B). Brain magnetic resonance imaging (MRI) demonstrated cortical dysplasia and subependymal nodules. There was no positive history of any family members suffering from TSC. (A) Cutaneous angiofibromas on the nose and cheek; (B) Shagreen patches on the back Intraorally, the patient presented with a single, ovoid, pedunculated, and reddish-brown swelling measuring approximately 0.8 x 0.7 x 0.3 cm, originating from the interdental papillary gingiva between the left mandibular permanent lateral incisor and canine (32, 33) (Fig. 2A). The lesion was firm and nontender, with a wrinkled surface. There was no history of pain, bleeding, ulcerations, or limitations in activity. The gingival sulcus in relation to 32, 33 was not associated with bleeding on probing. There was no mobility of the associated teeth, and radiographic findings were insignificant (Fig. 2B). The patient maintained good oral hygiene. A provisional diagnosis of an angiofibroma was arrived at, and an excisional biopsy was carried out. (A) Clinical presentation of the lesion; (B) Orthopantomogram revealing absence of intraosseous lesions and periodontal destruction adjacent to the lesion Histology revealed a hyperkeratotic, hyperplastic stratified squamous parakeratinized epithelium with thin elongated rete pegs overlying a fibrovascular stroma. The subjacent stroma was moderately cellular, with large spindle and stellate fibroblasts with prominent vesicular nuclei interspersed among dense collagen fiber bundles and a mild chronic inflammatory cell infiltrate (Fig. 3). In view of the histopathological characteristics, a conclusive diagnosis of giant cell fibroma was rendered. There was no evidence of recurrence at the end of a 1-year follow-up. Areas of large spindle and stellate fibroblasts with prominent vesicular nuclei (black arrow) noted (H&E; 10×) Discussion In TSC, multiple organ systems are affected by the development of hamartomatous lesions. It is caused by alterations in the tumor suppressor genes TSC1 and TSC2, which are mapped to chromosomal regions 9q34 and 16p13.3, respectively. Alterations in the TSC1 and TSC2 genes lead to dysregulated activation of the mammalian target of rapamycin (mTOR) signaling pathway. This results in disruption of normal cell processes, leading to the development of multisystem hamartomas.4 The World TSC Conference 2021 diagnostic framework serves as the basis for diagnosing TSC. Clinical diagnosis relies on identifying 11 major and six minor features. Major diagnostic features include hypomelanotic macules (≥3, at least 5-mm diameter), ungual fibromas (≥2), angiofibromas (≥3) or fibrous cephalic plaque, shagreen patch, multiple retinal hamartomas, subependymal nodules, multiple cortical tubers, cardiac rhabdomyoma, subependymal giant cell astrocytoma, lymphangioleiomyomatosis, and angiomyolipomas (≥2). Minor diagnostic characteristics encompass retinal achromic patches, “confetti” skin lesions, intraoral fibromas, nonrenal hamartomas, dental enamel pits (>3), multiple renal cysts, and sclerotic bone lesions. A definite diagnosis of the condition is established when either two major criteria are present, or when one major criterion is accompanied by at least two minor criteria.5 The confirmation of TSC in the current case was supported by the presence of four major diagnostic criteria (Shagreen patches, facial angiofibromas, cortical tubers, and subependymal nodules). Dermatologic manifestations involve hypopigmented patches that may be noticeable at birth or become apparent as the child grows, along with facial angiofibromas, which appear as symmetrically arranged reddish fibrovascular papules around the nose, chin, and cheeks; nontraumatic ungual and periungual fibromas; Shagreen patches, described as large bumpy lesions on the lower back; and “confetti-like” lesions, which appear as hypomelanotic macules.6 These patients may also present with neurologic manifestations, such as epilepsy and psychotic disorders. Other manifestations reported in literature include retinal hamartomas, renal angiomyolipomas, rhabdomyomas, and pseudocystic osseous lesions.3 Oral manifestations are noted in 11–56% of patients, and are usually diagnosed between 4 and 10 years of age, or during puberty.6 Enamel pits are the most common, followed by angiofibromas, predominantly located on the maxillary anterior gingiva.1,6 Other oral manifestations include macroglossia, cleft lip and palate, desmoplastic fibromas, bifid uvula, and myxomas.6,7 The present case is of a giant cell fibroma located on the mandibular anterior gingiva of a child with TSC, which, to the best of our knowledge, is the first case to be reported. Giant cell fibroma is a fibrous tissue mass that clinically mimics other fibrous proliferations and represents about 2–5% of all fibrous biopsy specimens.8 These lesions are most frequently seen during the second and third decades of life, show a mild predominance in females, and are usually found on the mandibular gingiva.9 A histological evaluation is required for the diagnosis of a giant cell fibroma. The lesion presents with large spindle or stellate-shaped, mononuclear and multinuclear fibroblasts. The origin of the stellate and multinucleated cells is still unknown. However, it has been suggested that these cells may originate from melanocytes or Langerhans cells.9 The treatment is surgical excision, and recurrence is rare.8 Considering the clinical presentation of the lesion, a preliminary diagnosis of angiofibroma was established. Moreover, angiofibromas are considered the second most common intraoral lesion found in patients with TSC.1 Irritation fibroma was eliminated as a provisional diagnosis, as the patient maintained good oral hygiene, and there was no source of chronic irritation. Medication-induced gingival enlargement was not considered, as it is a generalized condition. Conclusion Patients with TSC require regular medical and dental check-ups. Although we report no recurrence of the lesion at the end of a 1-year follow-up period, the chances of recurrence may be high, owing to the genetic alterations seen in these patients. Clinical Significance Dentists should familiarize themselves with the oral signs and symptoms of TSC. A giant cell fibroma should be considered as a differential diagnosis for intraoral fibrous lesions seen in these patients. Timely interventions will help improve the oral health-related quality of life of these patients. Orcid Olando Kevin D'souza https://orcid.org/0009-0002-4420-696X Rashmi Naik https://orcid.org/0009-0004-0491-7921 Siya Dukle https://orcid.org/0000-0002-0730-4627 Karla Carvalho https://orcid.org/0000-0002-4137-2105